• LinkedIn
  • Newsroom
  • Careers
  • Contact Us
Rising Pharmaceuticals
  • Welcome
  • Company
  • Leadership
  • Products
  • Menu Menu
  • Welcome
  • Company
  • Leadership
  • Products
  • Newsroom
  • Careers
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
You are here: Home1 / Products2 / Duloxetine DR Caps

Duloxetine DR Caps

20 mg / 60 count

Brand name: Cymbalta®

Duloxetine Delayed-Release Capsules USP are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for:

1. Major Depressive Disorder (MDD) (1.1)
2. Generalized Anxiety Disorder (GAD) (1.2)
3. Diabetic Peripheral Neuropathic Pain (DPNP) (1.3)

For more information please see the prescribing information on DailyMed.

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning.1) Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants (5.1) 2) Monitor for worsening and emergence of suicidal thoughts and behaviors (5.1) 3) Duloxetine delayed-release capsules are not approved for use in pediatric patients (8.4)

PRODUCT INFORMATION
PRODUCT CHARACTERISTICS
OTHER INFORMATION

Tab Content goes here

*The brand names listed are not owned by Rising Pharma. Rising Pharma products are generic equivalents to the respective brand names listed on this website.

Follow a manual added link

Read more about Rising’s response to the COVID-19 pandemic here.

Follow a manual added link

Read more about Rising’s response to the COVID-19 pandemic here.

From our manufacturers, partners and pharmacies to physicians and their patients, our goal is to make life better for everyone we impact.

Contact Us

Integrity

Responsibility

Service

Collaboration

Teamwork

© 2021 Rising Pharma Holdings, Inc. DBA Rising Pharmaceuticals. All Rights Reserved.
  • LinkedIn
  • Privacy Policy
  • Terms & Conditions
Scroll to top